Neurologic Disorders: Medical Cannabis Clinical Applications + Therapeutics January, 2021

546

Each US state has its list of qualifying conditions for medical cannabis and at least one neurologic condition is on each state’s list. These disorders include Alzheimer’s disease, Parkinson’s disease, and seizure disorders, epilepsy being the most common. Of note, children who present on the autism spectrum (ASD) have an increased risk of epilepsy. Currently and unfortunately, there are no cures for any of these disorders.

Pharmaceuticals can reduce the severity of the symptoms that are associated with each one of these disorders, but these associated side effects of the pharmaceutical medicines can be perhaps even more severe than the symptoms themselves. Medical cannabis has been shown to be effective in treating symptoms associated with these disorders and with far less unpleasant side effects. 

CannabizMD Founder/CEO Jacquie Cohen Roth, MS moderated a lively and informative roundtable discussion with leading medical cannabis experts Dr. Patricia Frye, Dr. Ethan Russo and Dr. Bonni Goldstein on treating neurologic disorders with medical cannabis and the relevant research.

Note: In order to view this video content, you must be a registered member of the CannabizMD Ecosystem. As a member, you will access to valuable content, discounts on all CannabizMD events and curated content.

Neurologic Disorders - Medical Cannabis Clinical Applications + Therapeutics

Neurologic Disorders: Medical Cannabis Clinical Applications + Therapeutics (January, 2021)

Previous articleChronic Pain: Medical Cannabis Clinical Application + Research November 16, 2020
Next articleAdult-Use Cannabis in Maryland